15 June 2021 | News
The app will provide patients to navigate the tough decisions throughout their treatment journey
CURIA app developed by Swiss company OncoCoin will enable cancer patients with individualised information on treatments, clinical trials and experts. The app will provide the patients with the much-needed support to navigate the tough decisions throughout their treatment journey. Built over the OncoCoin platform, CURIA offers services such as tailored information, second opinion and the opportunity to participate in research programmes.
The tailored options in the app seek to answer three main questions which are often at the forefront of patients' minds when they are diagnosed with cancer: ‘What are the treatment options available to me’, ‘What clinical trials could I participate in’, and ‘Who are the experts for my cancer type’.